Talaria Global Equity Fund - Foundation Units

Foundation Units are now closed to new investors.

Existing Investors: Please contact Talaria on (03) 9913 0702 or info@talariacapital.com.au to discuss your investment further.

To access the Talaria Global Equity Fund, new investors can invest via the Fund’s Wholesale Units.

Performance

As at

31/3/2020

1

< Scroll >

1
Month

3
Months

6
Months

1
Year

3 Years (pa)

5 Years (pa)

Since Inception (pa)2

Income %

1.48

1.47

2.37

6.18

7.37

7.36

6.90

Growth %

-10.62

-10.95

-10.32

-6.35

-2.59

-3.30

-0.20

Total Return %

-9.14

9.48

-7.95

-0.17

4.78

4.06

6.69

Average Market Exposure 5

64%

61%

59%

57%

61%

61%

62%

1 Fund Returns are calculated after fees and expenses and assume the reinvestment of distributions.
2 Inception date for performance calculations is 1 October 2005.
3 Income return includes realised capital gains.
4 Past performance is not a reliable indicator of future performance.
5 Average Market Exposure calculated on delta-adjusted exposure of underlying portfolio.

Top 10 holdings 8

Roche

Holdings %

6.6

Country

Switzerland

Sector

Healthcare

Description

World's largest biotech company, global leaders in cancer treatments, leader in R&D

WPP

Holdings %

4.8

Country

United Kingdom

Sector

Media

Description

World leader in advertising and marketing services

Sanofi

Holdings %

4.6

Country

France

Sector

Health Care

Description

Top 5 pharmaceutical firm with leading positions in diabetes and rare diseases

Johnson & Johnson

Holdings %

4.6

Country

USA

Sector

Health Care

Description

Pharmaceutical, medical devices and consumer health products company

McKesson

Holdings %

4.3

Country

USA

Sector

Health Care

Description

Largest pharmaceutical distributor in North America

Wheaton Precious Metals

Holdings %

4.3

Country

USA

Sector

Materials

Description

Large precious metals streaming company

Bayer

Holdings %

4.0

Country

Germany

Sector

Pharmaceuticals

Description

Multinational pharmaceutical and life sciences company

Prudential

Holdings %

4.0

Country

USA

Sector

Financials

Description

Largest Insurance company in the USA

Asahi Group

Holdings %

3.9

Country

Japan

Sector

Consumer Staples

Description

Japan's largest brewer with increasing overseas market presence

Swiss Re

Holdings %

3.9

Country

Switzerland

Sector

Insurance

Description

One of the world’s leading providers of insurance and reinsurance

Company Name

Holding %

Country

Sector

Description

Roche

6.6

Switzerland

Healthcare

World's largest biotech company, global leaders in cancer treatments, leader in R&D

WPP

4.8

United Kingdom

Media

World leader in advertising and marketing services

Sanofi

4.6

France

Health Care

Top 5 pharmaceutical firm with leading positions in diabetes and rare diseases

Johnson & Johnson

4.6

USA

Health Care

Pharmaceutical, medical devices and consumer health products company

McKesson

4.3

USA

Health Care

Largest pharmaceutical distributor in North America

Wheaton Precious Metals

4.3

USA

Materials

Large precious metals streaming company

Bayer

4.0

Germany

Pharmaceuticals

Multinational pharmaceutical and life sciences company

Prudential

4.0

USA

Financials

Largest Insurance company in the USA

Asahi Group

3.9

Japan

Consumer Staples

Japan's largest brewer with increasing overseas market presence

Swiss Re

3.9

Switzerland

Insurance

One of the world’s leading providers of insurance and reinsurance

8 Weightings include option positions held and cash backing put options. It assumes that put options will be exercised. Should the put option not be exercised the cash will revert to the unencumbered cash portfolio or may be used to cover further put options.

Sector Allocation 9

Regional Allocation 10

9,10 Weightings include option positions held and cash backing put options It assumes that put options will be exercised. Should the put option not be exercised the cash will revert to the unencumbered cash portfolio or may be used to cover further put options.

Fund Snapshot

As at

March 31, 2020

Management Fee
Nil
Inception Date
1 October 2005
Liquidity
Daily
Buy / Sell Spread
0.20% / 0.20%
Min Investment
$50,000
Distributions
Quarterly
Availability
Wholesale Clients Only

Reports and Disclosure Documents

Important Notice

Foundation Units in the Talaria Global Equity Fund are issued by Australian Unity Funds Management Limited ABN 60 071 497 115, AFS Licence No. 234454. Foundation Units are currently available to what the Corporations Act 2001 (Sections 761GA and 761G) defines as Wholesale Clients. Talaria Asset Management Pty Ltd ABN 67 130 534 342, AFS Licence No, 333732 is the investment manager and distributor of the Fund. References to “we” means Talaria Asset Management Pty Ltd, the investment manager. The information in this document is general information only and is not based on the financial objectives, situation or needs of any particular investor. In deciding whether to acquire, hold or dispose of the product you should obtain a copy of the current Information Memorandum and consider whether the product is appropriate for you. A copy of the Information Memorandum can be obtained by calling Talaria Asset Management on (03) 8676 0667. Investment decisions should not be made upon the basis of the Fund’s past performance or distribution rate, or any ratings given by a rating agency, since each of these can vary. In addition, ratings need to be understood in the context of the full report issued by the rating agency itself. The information provided in the document is current at the time of publication.

Wholesale Investor Confirmation

By clicking below you are confirming that you are an Australian wholesale client for the purposes of section 761G of the Corporations Act 2001. Access to this information is provided on the condition that it is not passed on to any person who is a retail client within the meaning of section 761G of the Corporations Act 2001.